Metabolism and Elimination BPC-157 undergoes rapid metabolic degradation into smaller peptide fragments and ultimately individual amino acids
Lilly says they have worked out dosing regimens that will improve on this
While human research remains limited, the consistency of animal findings supports the mechanism
When used as part of CagriSema, the dosing schedule looked like this in trials: Weeks 04: 0.25 mg cagrilintide + 0.25 mg semaglutide Weeks 48: 0.5 mg + 0.5 mg Weeks 812: 1 mg + 1 mg Weeks 1216: 1.7 mg + 1.7 mg Week 16 onward: 2.4 mg + 2.4 mg (full maintenance dose) Until the medication is approved and prescribing information is finalized, any dosing decisions would only happen through participation in a clinical trial or, eventually, under the guidance of a healthcare provider
Zheng, K., Yang, Z., & Ba, T